Table 1. Patient characteristics .... | American Society of Hematology

Table 1.

Patient characteristics

	GM-CSF priming	No priming	Total
Patients	25	28	53
Sex
Male	18	19	37
Female	7	9	16
Age
Median	46	46.5	46
Range	24-72	34-63	24-72
Karnofsky performance status
100	12	8	20
90	9	13	22
80	2	6	8
70	2	1	3
Diagnosis
Renal cell carcinoma	12	13	25
Melanoma	13	15	28
Prior therapy
Chemotherapy (low dose)	5	4	9
Immunotherapy	11	19	30
Hormonal therapy	1	0	1
Radiation therapy	6	4	10
None	11	9	2

	GM-CSF priming	No priming	Total
Patients	25	28	53
Sex
Male	18	19	37
Female	7	9	16
Age
Median	46	46.5	46
Range	24-72	34-63	24-72
Karnofsky performance status
100	12	8	20
90	9	13	22
80	2	6	8
70	2	1	3
Diagnosis
Renal cell carcinoma	12	13	25
Melanoma	13	15	28
Prior therapy
Chemotherapy (low dose)	5	4	9
Immunotherapy	11	19	30
Hormonal therapy	1	0	1
Radiation therapy	6	4	10
None	11	9	2